U.S. pharma big copyright scrapped two experimental weight loss supplements final year—a at the time-day by day capsule, lotiglipron, on account of elevated liver enzymes along with a twice-daily capsule, danuglipron, as a result of potent Unintended effects—but CEO Albert Bourla has stated the company is set to “play and win” from the bein